Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL4297454 (Abbv-744, ABBV-744) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
bromodomain containing 2/Bromodomain-containing protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293289] [GtoPdb: 1944] [UniProtKB: P25440] | ||||||||
ChEMBL | Inhibition of N-terminal His6-tagged human BRD2 BD1 (73 to 194 residues) after 1 hr by TR-FRET assay | B | 5.93 | pKi | 1162 | nM | Ki | J Med Chem (2020) 63: 5585-5623 [PMID:32324999] |
ChEMBL | Inhibition of N-terminal His6-tagged human BRD2 BD2 (348 to 455 residues) after 1 hr by TR-FRET assay | B | 8.34 | pKi | 4.6 | nM | Ki | J Med Chem (2020) 63: 5585-5623 [PMID:32324999] |
ChEMBL | Inhibition of C-terminal His6-tagged BRD2 BD2 (unknown origin) using H-YSGRGK(Ac)GGK(Ac)GLGK(Ac)-GGAK(Ac)RHRK-Biotin-OH as substrate incubated for 1 hrs by HTRF assay | B | 9.04 | pIC50 | 0.92 | nM | IC50 | J Med Chem (2022) 65: 5760-5799 [PMID:35333526] |
bromodomain containing 3/Bromodomain-containing protein 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795186] [GtoPdb: 2725] [UniProtKB: Q15059] | ||||||||
ChEMBL | Inhibition of BRD3 BD1 (unknown origin) after 1 hr by TR-FRET assay | B | 5.5 | pKi | 3140 | nM | Ki | J Med Chem (2020) 63: 5585-5623 [PMID:32324999] |
ChEMBL | Inhibition of BRD3 BD2 (unknown origin) after 1 hr by TR-FRET assay | B | 8.31 | pKi | 4.9 | nM | Ki | J Med Chem (2020) 63: 5585-5623 [PMID:32324999] |
ChEMBL | Inhibition of C-terminal His6-tagged BRD3 BD2 (unknown origin) using H-YSGRGK(Ac)GGK(Ac)GLGK(Ac)-GGAK(Ac)RHRK-Biotin-OH as substrate incubated for 1 hrs by HTRF assay | B | 9.06 | pIC50 | 0.88 | nM | IC50 | J Med Chem (2022) 65: 5760-5799 [PMID:35333526] |
bromodomain containing 4/Bromodomain-containing protein 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1163125] [GtoPdb: 1945] [UniProtKB: O60885] | ||||||||
ChEMBL | Binding affinity to BRD4 BD1 (unknown origin) assessed as dissociation constant by Discover X assay | B | 5.48 | pKd | 3300 | nM | Kd | J Med Chem (2021) 64: 10497-10511 [PMID:34236185] |
ChEMBL | Inhibition of BRD4-BD1 (unknown origin) assessed as dissociation constant by TR-FRET method | B | 6.28 | pKd | 520 | nM | Kd | J Med Chem (2022) 65: 5660-5674 [PMID:35348328] |
ChEMBL | Binding affinity to human partial length BRD4 BD2 expressed in bacterial expression system assessed as dissociation constant by BROMOscan assay | B | 8.68 | pKd | 2.1 | nM | Kd | J Med Chem (2021) 64: 10497-10511 [PMID:34236185] |
ChEMBL | Inhibition of BRD4-BD2 (unknown origin) assessed as dissociation constant by TR-FRET method | B | 8.8 | pKd | 1.6 | nM | Kd | J Med Chem (2022) 65: 5660-5674 [PMID:35348328] |
ChEMBL | Inhibition of human N-terminal His6 tagged BRD4 BD1 (57 to 168) residues expressed in Escherichia coli BL21(DE3) cells after 1 hr by TR-FRET assay | B | 6.28 | pKi | 520 | nM | Ki | J Med Chem (2020) 63: 5585-5623 [PMID:32324999] |
ChEMBL | Inhibition of BRD4 BD2 (unknown origin) | B | 6.28 | pKi | 520 | nM | Ki | J Med Chem (2021) 64: 2419-2435 [PMID:33616410] |
ChEMBL | Inhibition of human N-terminal His6 tagged BRD4 BD2 (352 to 457) residues expressed in Escherichia coli BL21(DE3) cells after 1 hr by TR-FRET assay | B | 8.8 | pKi | 1.6 | nM | Ki | J Med Chem (2020) 63: 5585-5623 [PMID:32324999] |
ChEMBL | Inhibition of BRD4 BD1 (unknown origin) | B | 8.8 | pKi | 1.6 | nM | Ki | J Med Chem (2021) 64: 2419-2435 [PMID:33616410] |
ChEMBL | Inhibition of NanoLuc-tagged BRD4 BD1 (unknown origin) expressed in human HeLa cells after 2 hrs by NanoBRET assay | B | 4.68 | pIC50 | 20700 | nM | IC50 | J Med Chem (2020) 63: 5585-5623 [PMID:32324999] |
ChEMBL | Inhibition of His-tagged BRD4 bromodomain 1 (unknown origin) using [Lys (5,8,12,16) Ac] H4(1-21) as substrate by fluorescence based assay | B | 6.48 | pIC50 | 327.5 | nM | IC50 | Eur J Med Chem (2021) 209: 112868-112868 [PMID:33077265] |
ChEMBL | Inhibition of BRD4-BD1 (unknown origin) preincubated for 30 mins followed by substrate addition and measured after 3 hr by HTRF assay | B | 6.52 | pIC50 | 299.75 | nM | IC50 | Eur J Med Chem (2022) 236: 114259-114259 [PMID:35395439] |
ChEMBL | Inhibition of C-terminal His6-tagged BRD4 BD1 (unknown origin) using H-YSGRGK(Ac)GGK(Ac)GLGK(Ac)-GGAK(Ac)RHRK-Biotin-OH as substrate incubated for 1 hrs by HTRF assay | B | 6.62 | pIC50 | 238 | nM | IC50 | J Med Chem (2022) 65: 5760-5799 [PMID:35333526] |
ChEMBL | Inhibition of NanoLuc-tagged BRD4 BD2 (unknown origin) expressed in human HeLa cells after 2 hrs by NanoBRET assay | B | 7.56 | pIC50 | 27.5 | nM | IC50 | J Med Chem (2020) 63: 5585-5623 [PMID:32324999] |
ChEMBL | Inhibition of His-tagged BRD4 bromodomain 2 (unknown origin) using [Lys (5,8,12,16) Ac] H4(1-21) as substrate by fluorescence based assay | B | 8.48 | pIC50 | 3.3 | nM | IC50 | Eur J Med Chem (2021) 209: 112868-112868 [PMID:33077265] |
ChEMBL | Inhibition of BRD4-BD2 (unknown origin) preincubated for 30 mins followed by substrate addition and measured after 3 hr by HTRF | B | 8.75 | pIC50 | 1.78 | nM | IC50 | Eur J Med Chem (2022) 236: 114259-114259 [PMID:35395439] |
ChEMBL | Inhibition of C-terminal His6-tagged BRD4 BD2 (unknown origin) using H-YSGRGK(Ac)GGK(Ac)GLGK(Ac)-GGAK(Ac)RHRK-Biotin-OH as substrate incubated for 1 hrs by HTRF assay | B | 9.19 | pIC50 | 0.65 | nM | IC50 | J Med Chem (2022) 65: 5760-5799 [PMID:35333526] |
bromodomain testis associated/Bromodomain testis-specific protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795185] [GtoPdb: 2729] [UniProtKB: Q58F21] | ||||||||
ChEMBL | Inhibition of BRDT BD1 (unknown origin) after 1 hr by TR-FRET assay | B | 6.04 | pKi | 917 | nM | Ki | J Med Chem (2020) 63: 5585-5623 [PMID:32324999] |
ChEMBL | Inhibition of BRDT BD2 (unknown origin) after 1 hr by TR-FRET assay | B | 9 | pKi | 1 | nM | Ki | J Med Chem (2020) 63: 5585-5623 [PMID:32324999] |
histone deacetylase 1/Histone deacetylase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL325] [GtoPdb: 2658] [UniProtKB: Q13547] | ||||||||
ChEMBL | Inhibition of HDAC1 (unknown origin) by fluorescence based assay | B | 5 | pIC50 | >10000 | nM | IC50 | Eur J Med Chem (2021) 209: 112868-112868 [PMID:33077265] |
histone deacetylase 6/Histone deacetylase 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1865] [GtoPdb: 2618] [UniProtKB: Q9UBN7] | ||||||||
ChEMBL | Inhibition of HDAC6 (unknown origin) by fluorescence based assay | B | 5 | pIC50 | >10000 | nM | IC50 | Eur J Med Chem (2021) 209: 112868-112868 [PMID:33077265] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]